{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T17:23:18Z","timestamp":1789233798948,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.clinre.2025.102685","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T15:52:44Z","timestamp":1757519564000},"page":"102685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Treatment modalities for metabolic dysfunction-associated steatotic liver disease (MASLD) in children and adolescent: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6799-2548","authenticated-orcid":false,"given":"Syed Muhammad Mehdi","family":"Zaidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunoot","family":"Irfan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahmah","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulekha","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamna","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Hasan","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Hassan","family":"Alvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiq","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Zehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clinre.2025.102685_bib0001","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jhep.2023.08.030","article-title":"Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): beyond insulin resistance","volume":"79","author":"Hutchison","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2025.102685_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1083032","article-title":"Prediction of MAFLD and NAFLD using different screening indexes: a cross-sectional study in U.S. adults","volume":"14","author":"Peng","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.clinre.2025.102685_bib0004","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jad.2024.02.074","article-title":"Depression and NAFLD risk: a meta-analysis and mendelian randomization study","volume":"352","author":"Li","year":"2024","journal-title":"J Affect Disord"},{"issue":"18","key":"10.1016\/j.clinre.2025.102685_bib0003","doi-asserted-by":"crossref","first-page":"9924","DOI":"10.3390\/ijms25189924","article-title":"Converging pathways between metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes in children","volume":"25","author":"Faienza","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.clinre.2025.102685_bib0005","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.jhep.2023.08.018","article-title":"Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: nationwide multigenerational cohort study","volume":"79","author":"Ebrahimi","year":"2023","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.clinre.2025.102685_bib0006","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a State-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"issue":"1","key":"10.1016\/j.clinre.2025.102685_bib0007","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/gutjnl-2024-332398","article-title":"Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma","volume":"74","author":"Ha","year":"2024","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.clinre.2025.102685_bib0008","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1186\/s12889-024-19378-w","article-title":"Efficacy of the Mediterranean diet in treating metabolic dysfunction-associated steatotic liver disease (MASLD) in children and adolescents: a systematic review and meta-analysis","volume":"24","author":"Jamil","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.clinre.2025.102685_bib0010","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S1665-2681(19)31820-4","article-title":"Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)","volume":"8","author":"Bellentani","year":"2008","journal-title":"Ann Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2025.102685_bib0012","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/liv.14478","article-title":"What's in a name? Renaming \u2018NAFLD\u2019 to \u2018MAFLD\u2019","volume":"40","author":"Fouad","year":"2020","journal-title":"Liver Int"},{"issue":"19","key":"10.1016\/j.clinre.2025.102685_bib0013","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1097\/CM9.0000000000000981","article-title":"From NAFLD to MAFLD: a \u201credefining\u201d moment for fatty liver disease","volume":"133","author":"Zheng","year":"2020","journal-title":"Chin Med J"},{"issue":"7","key":"10.1016\/j.clinre.2025.102685_bib0014","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.medj.2024.03.017","article-title":"An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease","volume":"5","author":"Zhang","year":"2024","journal-title":"Med"},{"issue":"10","key":"10.1016\/j.clinre.2025.102685_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140908","article-title":"The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis","volume":"10","author":"Anderson","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.clinre.2025.102685_bib0011","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12887-022-03351-w","article-title":"Epidemiology and lifestyle survey of non-alcoholic fatty liver disease in school-age children and adolescents in Shenyang, Liaoning","volume":"22","author":"Lin","year":"2022","journal-title":"BMC Pediatr"},{"issue":"9","key":"10.1016\/j.clinre.2025.102685_bib0018","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.26719\/emhj.20.023","article-title":"Adherence to the Mediterranean diet of school-age children in Moroccan oases, Draa-Tafilalet Region","volume":"26","author":"Azekour","year":"2020","journal-title":"East Mediterr Health J"},{"issue":"4","key":"10.1016\/j.clinre.2025.102685_bib0019","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/diseases5040023","article-title":"An overview of dietary interventions and strategies to optimize the management of non-alcoholic fatty liver disease","volume":"5","author":"Perumpail","year":"2017","journal-title":"Diseases"},{"issue":"4","key":"10.1016\/j.clinre.2025.102685_bib0015","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.12872","article-title":"The effects of mediterranean diet on hepatic steatosis, oxidative stress, and inflammation in adolescents with non-alcoholic fatty liver disease: a randomized controlled trial","volume":"17","author":"Yurtda\u015f","year":"2022","journal-title":"Pediatr Obes"},{"issue":"7","key":"10.1016\/j.clinre.2025.102685_bib0016","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/liv.13435","article-title":"The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: evidence and plausible mechanisms","volume":"37","author":"Zelber-Sagi","year":"2017","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.clinre.2025.102685_bib0017","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/09637486.2021.1979478","article-title":"The effect of a mediterranean diet vs. a low-fat diet on non-alcoholic fatty liver disease in children: a randomized trial","volume":"73","author":"Akbulut","year":"2022","journal-title":"Int J Food Sci Nutr"},{"issue":"8","key":"10.1016\/j.clinre.2025.102685_bib0022","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.3390\/nu6083187","article-title":"Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD","volume":"6","author":"Jin","year":"2014","journal-title":"Nutrients"},{"issue":"24","key":"10.1016\/j.clinre.2025.102685_bib0023","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150996","article-title":"Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease","volume":"131","author":"Cohen","year":"2021","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.clinre.2025.102685_bib0024","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.12630","article-title":"Effects of a carbohydrate-restricted diet on hepatic lipid content in adolescents with non-alcoholic fatty liver disease: a pilot, randomized trial","volume":"15","author":"Goss","year":"2020","journal-title":"Pediatr Obes"},{"issue":"3","key":"10.1016\/j.clinre.2025.102685_bib0025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/chi.2013.0022","article-title":"A low-glycemic-load versus low-fat diet in the treatment of fatty liver in obese children","volume":"9","author":"Ramon-Krauel","year":"2013","journal-title":"Child Obes"},{"issue":"3","key":"10.1016\/j.clinre.2025.102685_bib0026","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MPG.0000000000001422","article-title":"Effects of probiotics on nonalcoholic fatty liver disease in obese children and adolescents","volume":"64","author":"Famouri","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"10.1016\/j.clinre.2025.102685_bib0027","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3345\/cep.2021.00787","article-title":"Effects of probiotics combined with dietary and lifestyle modification on clinical, biochemical, and radiological parameters in obese children with nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis: a randomized clinical trial","volume":"65","author":"Rodrigo","year":"2022","journal-title":"Clin Exp Pediatr"},{"issue":"2","key":"10.1016\/j.clinre.2025.102685_bib0028","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3945\/jn.113.185561","article-title":"Antioxidant supplements reduced oxidative stress and stabilized liver function tests but did not reduce inflammation in a randomized controlled trial in obese children and adolescents","volume":"144","author":"Murer","year":"2014","journal-title":"J Nutr"},{"key":"10.1016\/j.clinre.2025.102685_bib0029","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/s12887-024-04993-8","article-title":"Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial","volume":"24","author":"Al-Baiaty","year":"2024","journal-title":"BMC Pediatr"},{"issue":"16","key":"10.1016\/j.clinre.2025.102685_bib0030","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of Vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.clinre.2025.102685_bib0034","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MEG.0000000000002964","article-title":"Effect of high-intensity interval training on clinical parameters in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Fu","year":"2025","journal-title":"Eur J Gastroenterol Hepatol [Internet]"},{"key":"10.1016\/j.clinre.2025.102685_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120695","article-title":"Vildagliptin alleviates liver fibrosis in NASH diabetic rats via modulation of insulin resistance, oxidative stress, and inflammatory cascades","author":"Hendawy","year":"2022","journal-title":"Life Sci [Internet]"},{"issue":"4","key":"10.1016\/j.clinre.2025.102685_bib0032","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/08998280.2024.2335829","article-title":"Efficacy of orlistat in obese patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Mahmoud","year":"2024","journal-title":"Proc (Bayl Univ Med Cent) [Internet]"},{"issue":"2","key":"10.1016\/j.clinre.2025.102685_bib0033","article-title":"Liver-specific actions of GH and IGF1 that protect against MASLD","volume":"21","author":"Kineman","year":"2025","journal-title":"Nat Rev Endocrinol [Internet]"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125001627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125001627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T03:00:09Z","timestamp":1761966009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740125001627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2210740125001627"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102685","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment modalities for metabolic dysfunction-associated steatotic liver disease (MASLD) in children and adolescent: A systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102685"}}